Search

Author/Creator Guchelaar, H.‐J.

1. Early prediction of thiopurine‐induced hepatotoxicity in inflammatory bowel disease. Issue 3 (12th December 2016)

Authors:
Wong, D. R.; Coenen, M. J. H.; Derijks, L. J. J.; Vermeulen, S. H.; van Marrewijk, C. J.; Klungel, O. H.; Scheffer, H.; Franke, B.; Guchelaar, H.‐J.; de Jong, D. J.; Engels, L. G. J. B.; Verbeek, A. L. M.; Hooymans, P. M.
Other Names:
Masclee AAM investigator.; Pierik M investigator.; Mares W investigator.; Hameeteman W investigator.; Wahab PJ investigator.; Seinen H investigator.; Rijk MCM investigator.; Harkema IM investigator.; de Bièvre M investigator.; Oostenbrug L investigator.; Bakker CM investigator.; Aquarius M invest...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 45:Issue 3(2017)
Page Start:
391
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Risk factors for thiopurine‐induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype. Issue 10 (15th September 2017)

Authors:
Broekman, M. M. T. J.; Coenen, M. J. H.; Wanten, G. J.; van Marrewijk, C. J.; Klungel, O. H.; Verbeek, A. L. M.; Hooymans, P. M.; Guchelaar, H.‐J.; Scheffer, H.; Derijks, L. J. J.; Wong, D. R.; de Jong, D. J.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 46:Issue 10(2017)
Page Start:
953
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search